1. Canopy Growth Corporation Reports Third Quarter Fiscal 2019 Financial Results:
  2. Treating Yourself Relaunches Medical Cannabis Website
  3. Sunniva Announces Completion of $15 Million Convertible Debenture Financing
  4. Supreme Cannabis Announces Q2 2019 Financial Results
  5. ‘This is the new Vitamin C’: Biome Grow to sign major CBD source deal
  6. Could Cannabis Cosmeceuticals be the Next Billion Dollar Idea?
  7. Biome Grow announces Memorandum of Understanding to purchase up to 20,000 kg per year of hemp-grown CBD extract from industrial hemp grower CBD Acres
  8. Aurora Releases Q2 Financial Results
  9. O’Cannabiz Toronto Expo, Conference & Industry Awards April 25-27 2019
  10. Biome Grow announces first shipment of finished product to Newfoundland and Labrador
  11. Supreme Cannabis Expands Domestic Distribution to Eight Provinces
  12. 48North Closes its $10 million Private Placement
  13. Aphria’s Board of Directors Rejects Green Growth Brand’s Hostile Takeover Bid
  14. Planet 13 Announces Customer Traffic for January 2019
  15. iAnthus and MPX Bioceutical Announce Closing of $1.6 Billion Business Combination
  16. Namaste Board Launches Strategic Review Process; Announces Termination of CEO Sean Dollinger and Commences Legal Action
  17. World Health Organization Recommends Rescheduling Marijuana Under International Treaties
  18. What Drove Altria’s Revenue in the Fourth Quarter?
  19. Surprise! Tilray’s CEO Just Dumped $11 Million in Stock
  20. Origin House Signs Exclusive Distribution Agreement and Provides Strategic Financing to Utopia Cannabis
  21. Slang, a Canopy Growth-backed Cannabis Company on CSE, off to Half-Billion Dollar Valuation
  22. PharmaCielo Establishes Joint Venture with Mino Labs to Bring Medicinal Cannabis Oil to Mexico
  23. Origin House Signs Exclusive Agreement with Viola Brands for California
  24. TGOD Completes Knud Jepsen Agreement
  25. Green Growth Brands Files Offer to Purchase and Circular for Aphria Inc.; Aphria Urges Shareholders to “Take No Action”
  26. MPX Receives Final Court Approval for Arrangement with iAnthus
  27. Invictus MD Announces Submission Of Its Application To List On NASDAQ And Share Consolidation
  28. HEXO to Begin Trading on the NYSE American, Announces Results of AGM
  29. Nova Scotia’s Highland Grow Secures Second Purchase Order with the NSLC
  30. MPX Securityholders Approve Business Combination with iAnthus
  31. Invictus and GTEC Holdings Announce Formal Termination Of Merger Plans
  32. Biome Opens the Door to U.S. Investors
  33. Aleafia Fulfills First Transaction Under Cannabis Supply Agreement with CannTrust
  34. Aurora to Acquire Whistler
  35. Aphria Releases Q2 Results as Founders Step Down
  36. Curaleaf Set To Expand Operations In Maryland With New Financing And Purchase Option Agreements
  37. PharmaCielo Announces TSX Venture Listing and Provides Corporate Update
  38. Emerald Health Closes Emerald Health Naturals Joint Venture
  39. Biome Grow subsidiary, Highland Grow secures purchase order with NSLC and sends first shipment of finished product
  40. SUPREME CANNABIS RECEIVES CONDITIONAL APPROVAL TO LIST ON THE TORONTO STOCK EXCHANGE
  41. KUSHCO HOLDINGS REPORTS FIRST FISCAL QUARTER 2019 RESULTS
  42. Aurora Cannabis Provides Guidance for the Second Quarter of Fiscal 2019, Anticipating Net Revenues of $50M to $55M
  43. Curaleaf Launches Its 20th Medical Marijuana Dispensary in Florida
  44. iAnthus Opens Flagship Citiva Dispensary in Brooklyn
  45. TGOD Signs a Commercial Sublicense with EnWave and Tilray to Dry Cannabis in Canada
  46. The Fastest-Growing Marijuana Stocks in 2019
  47. Biome Announces OTCQB Listing
  48. Green Growth Brands Launches Hostile Takeover Bid for Aphria Inc.
  49. Cannabis Stocks Mixed on Monday
  50. Health Canada Announces Proposed Regulations for Cannabis Edibles, Extracts, and Topicals
  51. Northland Capital Initiates Coverage on Planet 13 Holdings
  52. Details on Ontario’s New Private Cannabis Retail Lottery
  53. GrowHealthy Opens First Flagship Dispensary in Florida, With Plans for Two More by End of 2018
  54. Biome Grow Receives Amended Health Canada Sales License for its Nova Scotia-based Highland Grow.
  55. Canada’s Largest Province To Approve Only 25 Store Licences Due to Supply Shortage
  56. The Next Cannabis Wave? A $3.7 Trillion Wellness Market
  57. Canopy Growth announces multi-year extraction agreement with Valens GroWorks
  58. Here’s Why Marijuana Stocks Deserve Coal in Their Stockings This Year
  59. Biome Receives DTC Eligibility in United States, OTC symbol “ORTFF”
  60. U.S. House of Representatives Passes the Farm Bill
  61. Mississauga and Markham Opt-Out of Cannabis Retail Stores
  62. Interview with Diane Scott, Chairman and Chief Executive Officer, Jamaican Medical Cannabis Corporation (JMCC)
  63. Canada’s Aurora Cannabis buys Mexico’s Farmacias Magistrales
  64. Altria Moves into the Herd
  65. Cronos group inc. Announces c$2.4 billion strategic investment from altria group, inc
  66. Canopy Acquires Storz & Bickel
  67. CANNABIS MEETS HEALTHCARE
  68. Aphria Shares Down this Morning
  69. 48North Has Two Major Announcements
  70. Cannabis stock report: Congress agrees on new farm bill legislation, CBD industry readies to explode
  71. Cannabis Daily’s Top 35 Stocks Now Updated
  72. iAnthus Announces Third Quarter 2018 Financial Results
  73. Green Thumb Industries (GTI) Announces Year-over-Year Revenue Growth of 344% and Sequential Revenue Growth of 26% for Third Quarter 2018
  74. 48North Cannabis Corp. Announces Revenue Growth for Fiscal Q1 2019
  75. KUSHCO HOLDINGS REPORTS FISCAL YEAR 2018 RESULTS
  76. Canada’s Grand Cannabis Experiment Has Set Scientists Free
  77. What Did Canadian Cannabis Legalization Do to the Stock Markets?
  78. Cannabis 3.0?
  79. Cannabis firms spent millions marketing their pot last quarter – did it work?
  80. Biome Grow, Now Publicly Traded but Falling Under the Radar
  81. John Boehner-Backed Pot Firm Sees This Boosting U.S. Weed Listings
  82. MJBizCon Las Vegas Redefines Scale in Cannabis Trade Shows
  83. Ontario Establishes Strict Regulations for the Licensing and Operation of Private Cannabis Stores
  84. Canopy Growth Losses Widen Sharply, But Cannabis Sales Prices Spike
  85. Biome Grow subsidiary, Highland Grow, receives license to sell to other licensed producers from Health Canada
  86. Université de Moncton partners with the Government of Canada, Genome Atlantic, Genome Canada, New Brunswick Innovation Foundation, and Organigram to advance cannabis research and increase productivity
  87. Aurora Cannabis Earnings Kick Off Big Week For Marijuana Stocks After Canada Recreational Legalization
  88. Legalization… What’s Next?  Clear the Smoke at O’Cannabiz Conference and Expo Vancouver
  89. Biome Grow announces supply and production agreement with Province of Newfoundland and Labrador, including distribution and retail services
  90. Trump ousts Jeff Sessions as attorney general
  91. Marijuana Stocks Moved Higher On Election Results
  92. Is the cannabis industry armed against privacy breaches?
  93. Is Emblem Corp (CVE:EMC) A Financially Sound Company?
  94. Midterm elections and marijuana: Part III, recreational use initiatives
  95. Biome Grow’s Announcement in Newfoundland Demonstrates its Large-Scale Commitment to Atlantic Canada
  96. Cannabis Stocks Reversed Some Losses Last Week
  97. O’Cannabiz Vancouver Brings Together Montel Williams, Leading Cannabis Advocates and Innovators
  98. Forget October: Here’s the Right Marijuana Move for Investors Now
  99. Better Marijuana Stock: Canopy Growth vs. Canopy Rivers
  100. Biome Grow (BIO.C) signs huge supply deal with Newfoundland
  101. Aurora Cannabis Receives Lenders’ Consent for Proposed Acquisition of ICC
  102. Spectrum Cannabis welcomes JWC dried cannabis products to its online platform
  103. 3 Marijuana Stocks Taking Advantage of Global CBD Growth
  104. Falling Pot Stocks Hammer Canada’s Struggling Venture Exchange
  105. Cannabis Sector Didn’t Fare So Well Last Week
  106. How Pot Chain MedMen Sounds Like A Typical Retailer With This New Plan
  107. Biome Grow Introduces Ontario-based brand, Great Lakes Cannabis
  108. Kushco Holdings Joins Sustainable Packaging Coalition
  109. Sales of Marijuana in Colorado Continue to Climb
  110. Monday Morning Coming Down
  111. Biome Grow Introduces PEI Brand, Red Sands Craft Cannabis Co.
  112. Mary’s Wellness Pitching CBC Dragon’s Den Tonight
  113. Biome Grow Announces Listing on the Frankfurt Stock Exchange under symbol 60TA
  114. Home-Use THC and CBD Test Kits Now Available in Canada
  115. Looking for Work in Cannabis? Careers Cannabis’ New Platform Launches Today
  116. Canada becomes first industrialised nation to legalise cannabis
  117. Biome Grow is Investing in Atlantic Canadian Cannabis Sector
  118. The Canadian Province With The Most Pot Smokers Was Just Revealed And It’s Not At All Who You Thought It Would Be
  119. The Cannabis Society and Fireside Cannabis presents Canada’s Legalization party.
  120. Cannabis companies ramp up marketing as Health Canada warns them not to advertise pot
  121. CBP Statement on Canada’s Legalization of Marijuana and Crossing the Border
  122. Flower One Commences Trading on the CSE
  123. Canopy Growth Completes First Legal Medical Cannabis Export from Canada to the United States
  124. Aurora Cannabis Announces Application to List on the NYSE
  125. BIOME GROW Begins Trading on CSE Under Symbol (BIO)
  126. Remember When?
  127. NICHE Canada’s Cannabis & Our Community Series Continues in Calgary October 23rd
  128. Biome Grow Closes Fundamental Change Transaction
  129. 10 Of The Richest Cannabis Millionaires — And How They Made Their Money
  130. Cannabis Sector Down After Pepsi’s Statement
  131. Rumors of a Crop Failure at Canopy’s Aldergrove, BC Facility
  132. Dixie Brands, Inc. Going Public, Expanding Operations
  133. As Major Beverage Companies Eye Cannabis Industry, Consumer Trends Expected to Follow Suit
  134. Cannabis company withdraws ‘Chronic by Dre’ trademark it filed without Dr. Dre’s permission
  135. Aphria unveils comprehensive portfolio of adult-use brands
  136. DEA Greenlights Epidiolex. What’s Next for CBD and the Cannabis Industry?
  137. SUPREME CANNABIS SIGNS CANNABIS SUPPLY AGREEMENT WITH TILRAY®
  138. New Ontario Cannabis Regulations Could Be a Breath of Fresh Air
  139. Our first exposure to The Cannabis Society both eye-opening and insightful
  140. Cannabis Sector Stayed in the Green Last Week
  141. Aurora Cannabis releases earnings, confirms U.S. listing plans
  142. Who is Biome Grow and What a Good Business Plan Means to Cannabis Investors
  143. Keep your arms and legs in the car at all times…
  144. Aphria Signs Supply Agreements with all Provinces and Yukon
  145. The Stock That Can’t Stay Out of the News
  146. Tilray Led Cannabis Stocks Higher as Sector Continues to Rally
  147. Tilray Drops Namaste Contract
  148. Coca-Cola and Aurora. Is it the Real Thing?
  149. CEO Hotline – Greg Pantelic, Think AHLOT Corporation
  150. Global Cannabis Partnership Welcomes New Members
  151. iAnthus Capital Holdings, Inc. Announces $30 Million Bought Deal Financing
  152. Organigram signs supply agreement with Newfoundland and Labrador Liquor Corporation
  153. Aphria Announces Director Resignation and Appointment
  154. Emblem launches Atmosphere, Its First Oral Dose-Metered Spray
  155. Organigram invests in Hyasynth Biologicals Inc.
  156. Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
  157. Insights on the Cannabis Industry
  158. Rolling Stone: New Report Predicts CBD Market Will Hit $22 Billion by 2022
  159. NICHE Canada and Aurora Cannabis Launch Guide for Municipal Candidates on Cannabis Legalization and Implementation
  160. Aurora Cannabis-ICC Labs Deal Fuels Marijuana Stock Momentum
  161. EVENT: Cannabis & Our Community – Toronto, Sept 25, 2018
  162. Invictus CEO Update: Building a vertically integrated, horizontally diverse cannabis company
  163. Cannabis Daily and Puffin Style Media Sponsorships
  164. Marijuana Stocks: Short-Seller Citron Research Puts Tilray Stock In Cross Hairs
  165. Demystifying the Science and Economics of Smart Temperature and Humidity Control
  166. Vertical Integration
  167. Take a Deep Dive into Highland Grow’s Antigonish, Nova Scotia Operation
  168. Emerald Health Therapeutics Reports 2nd Quarter 2018 Financial Results and Provides Corporate Update
  169. iAnthus Announces Second Quarter 2018 Financial Results
  170. Starseed Holdings Inc. Launches Saturday, its New Adult-Use Cannabis Brand
  171. Supreme Cannabis Secures Supply Agreements with Nova Scotia and Prince Edward Island
  172. Nova Scotia cannabis distributor hopes local products will be on NSLC shelves by Oct. 17
  173. Cannabis ETF Surges as Alcohol Industry Looks to Marijuana
  174. Aphria selected by the Nova Scotia Liquor Corporation to supply Nova Scotia’s adult-use cannabis market
  175. AB InBev, Pepsi, Coca-Cola All Likely Eyeing Cannabis: Former Alcohol Industry Exec
  176. Biome Grow announces conditional approval for listing on the Canadian Securities Exchange
  177. The Best Under-the-Radar Marijuana Stock I’ve Seen So Far
  178. Biome Grow – Investor Awareness Event
  179. Pot stocks rampage amid expectations of more big deals with traditional companies
  180. Cannabis Daily Launches Cannabis Lifestyle Website
  181. Organigram signs supply agreement with Nova Scotia Liquor Corporation
  182. Cannabis Drinks Expo Announces Canopy Growth Corp. CEO Bruce Linton Will Headline Event
  183. Aurora Cannabis Obtains Health Canada Approval for Softgel Capsule Production: Launches CanniMed Capsules 3:3
  184. The MJBizCon Int’l Conference Brought American Canna-Business to Toronto
  185. Aphria Signs Agreement with OCS
  186. The OCS Announces its Suppliers
  187. Emerald Health Therapeutics Announces Appointment of Pure Sunfarms President and CEO
  188. Weed’s Big Day
  189. The Green Organic Dutchman Signs Agreement to Acquire Leading European CBD Company HemPoland
  190. Let's Face It: Marijuana Stocks Won't Live Up to the Hype
  191. Aurora Cannabis and MedReleaf Confirm Supply Agreements with Ontario Cannabis Stores
  192. Organigram becomes an official cannabis supplier to the Province of Ontario, Canada’s largest adult recreational market
  193. Canopy Growth secures over 100 product listings in Ontario
  194. The Google of Cannabis? Hmm…
  195. Dry Counties
  196. TGOD Reports $8.5M Loss for Quarter ended June 30, 2018
  197. Kush Bottles Launches Their Canadian Division
  198. Cannabis company Canopy Growth’s stock soars 30% as Corona brewer increases stake
  199. Aurora Cannabis and McGill University Partner in International Research Project
  200. Constellation Brands makes additional $4 billion investment in cannabis company Canopy Growth
  201. Are Cannabis Investors Forgetting the Lessons of the Dot Com Era? First-to-Market May Not Win.
  202. THC BioMed Develops Cannabis Beverage
  203. What’s the Analyst Consensus on Aphria?
  204. Canopy Growth Completes Canopy Health Innovations Acquisition
  205. Has Canadian Marijuana Officially Bypassed Mainstream and Gone Corporate?
  206. How Trump’s trade battles are affecting the marijuana industry
  207. Aphria Records Higher Annual Sales and Higher Quarterly Loss Due to Pending Canadian Legalization
  208. 48North Invites Women To Speak-Up About Their Cannabis Use
  209. ABcann to Acquire Leading B.C. Producer Canna Farms
  210. Ontario said to announce big change in plans for marijuana retailing under Doug Ford
  211. The Greenfield 4:20 Fire and its Implications
  212. Aurora Cannabis and MedReleaf Close the World’s Largest Cannabis Industry Transaction
  213. CEO Hotline: Khurram Malik, Interim CEO, Biome Grow
  214. Marijuana operator Acreage Holdings announces landmark $119 million funding
  215. Cannabis Sector Continued to Slide Last Week
  216. Aphria provides update on investments
  217. Aurora, MedReleaf shareholders clear path toward Canada’s largest cannabis deal
  218. Step into the first virtual reality cannabis dispensary
  219. One Stop Shops? Not with the Kids. NSLC Shows Their Store.
  220. Khiron Appoints Former Mexican President Vicente Fox to Board of Directors
  221. Selling Cannabis in Jamaica – Wait…What?
  222. Aurora Cannabis Selects Shopify to Power Global ECommerce Platform
  223. British Columbia’s Liquor Board Announces the Province’s 31 Bud Suppliers
  224. Kush Bottles Reports Third Fiscal Quarter 2018 Results, Name Change and Restructuring
  225. Canopy Growth Moves to Acquire Hiku Brands Company
  226. Biome Grow Announces Appointment of Steven Poirier to its Board of Directors
  227. Alberta Announces the ‘Lucky 13’
  228. Canada to legalise smoking pot: Can these stocks smoke the ASX?
  229. Legal Marijuana Is Coming to Canada. Investors Catch the Buzz.
  230. Analyst Recommendations for Two Leading Cannabis Stocks
  231. Cannabis Promotion in Canada? See Tobacco. Tobacco Promotion in Canada? See Kryptonite.
  232. CEO of the Green Organic Dutchmen Resigns, New CEO and CFO Appointed
  233. 3 Best Marijuana Stocks of 2018 So Far — Are They Buys Now?
  234. CEO Hotline: The Cannabis Executive Search Agency
  235. Canadian Company Makes Historic Investment in Jamaican Medical Cannabis Research
  236. Orca Touchscreen Technologies Shareholders Approve Amalgamation with Biome Grow
  237. Why Canopy Growth Corp’s Shares Plunged 12% Today
  238. TGOD Holdings Accelerates European Expansion with Denmark Joint Venture
  239. Cann Group secures Australia’s largest medicinal cannabis operation
  240. Top Four Developments We’re Watching in Cannabis Sector: Part 2
  241. Aurora Cannabis signs loan deal for up to $250 million with Bank of Montreal
  242. Cannabis Drinks Gaining Visibility
  243. B.C. Announces Central Cannabis Warehouse and Online Platform
  244. Six Key Differentiation Points for the Cannabis Market in Canada
  245. Canada Legalizes Recreational Marijuana: What’s Next for Pot Stocks?
  246. Cultivator Catalyst Corp to go public with tech firm Orca
  247. Move Over Tech: Marijuana Stocks Are the New Star
  248. The Post-Prohibition Era in Canada Begins
  249. Canadian Senate Approves Bill C-45
  250. High Times refreshes IPO plans as cannabis companies build buzz on Wall Street
  251. Weed VR – Future Tech Today
  252. 48North Launches Scholarship Program for Entrepreneurial Women in Cannabis
  253. CannTrust strives to be a leader in the cannabis industry with a 450,000 square foot facility in Niagara, ON.
  254. Biome Grow announces agreement to acquire Weed Virtual Retail
  255. Here’s how Canada compares with the rest of the world when it comes to cannabis legalization
  256. CannabisMD and CBD’s Medicinal Application
  257. Khiron Life Sciences First To Enter 5-Million Strong Colombia Medical Cannabis Market
  258. House of Commons to Reinstate Rights of Canadians to Grow Cannabis
  259. Welcome to Cannada -Part 3. The New Cannabis Economy
  260. Cannabis Delivery Services: Curation and Connection
  261. Avoid These Obvious Mistakes When Investing In Cannabis Stocks
  262. 5 Must-See Quotes From Aurora Cannabis on Worldwide Weed Opportunities
  263. Trump Signals Support for Legislation Easing US Ban on Pot
  264. Large Indoor Hydroponic Facility – New On the CSE
  265. A Hitchhiker’s Guide to Recreational Cannabis
  266. CEO of Lift & Co’s Consumer-Centric Vision
  267. On the Morning of Canadian Senate Vote, Weed Stocks Down
  268. 2nd Annual O’Cannabiz Conference Toronto
  269. Now Growing More Than Tomatoes & Cucumbers
  270. Welcome to Cannada -Part 2. The Cannabis Stock Exchange
  271. Newfoundland and Labrador’s Back Home Medical Cannabis Corp. becoming a reality thanks to investment from Biome Grow
  272. Welcome to Cannada. Part I – The Canadian Cannabis Future
  273. Deloitte Reports that Canadians Will Spend $7.2B Next Year on Cannabis
  274. As C-45 Passage Approaches, Greg Engel, CEO of OrganiGram, Shares His Thoughts
  275. Organigram Enters into Non-Binding Term Sheet for 26% Equity Interest in Eviana Health Corporation
  276. On the Verge of Becoming Canada’s Largest Cannabis Producer
  277. Khiron Life Sciences Corp. New on the TSX – Medical Cannabis for Latin America
  278. C-45 Progresses in the Canadian Senate as the Industry Ramps Up
  279. 8 Canadian Marijuana Growers Expected to Top 100,000 Kilograms of Annual Production
  280. Canopy Growth Announces Five Retail Locations in Saskatchewan
  281. MedMen CEO Sees Untapped Potential in Marijuana Market
  282. Canopy Growth Corporation announces entry into the African market with acquisition of Daddy Cann Lesotho
  283. Meet Nova Scotia’s 3 legal cannabis growers
  284. JMCC Aims to Supply Canadian LPs with Jamaican Premium Cannabis
  285. MedMen Begins Trading Under Ticker Symbol “MMEN” on the Canadian Securities Exchange
  286. MedReleaf and BioPharma Services Inc. Announce Strategic Alliance
  287. Cannabis Sector Back in the Red for Week Ended May 25
  288. What Investors Are Paying for Cannabis Sector’s Forward Sales
  289. As Ontario Votes, We Ask the Candidates Where They Stand on Cannabis.
  290. Biome announces acquisition of land in Nova Scotia to dramatically increase the production footprint of its ACMPR Licensed Producer
  291. With Legalization Colorado Invited Growers into the State. Here’s What Happened
  292. Looking for Work Women? Perhaps the Grass is Greener in the Cannabis Industry
  293. Organigram Announces Letter of Intent for Strategic Investment in Hyasynth Biologicals Inc.
  294. Highland Grow Inc. Boosts its Quality Assurance and Regulatory Compliance Ranks
  295. Lift & Co. Cannabis Expo Illustrates the Changing Nature of the Business
  296. Diagnostics, Testing and Support – The Coming Wave
  297. From the Big Smoke to the Big Board
  298. Biome Grow expects completion of first province-based cannabis production facility this year
  299. Oils – Are They Secret Sauce to Profitability?
  300. Organigram Receives Permit to Export Medical Cannabis to Australia
  301. Morning Briefing -Top 9 Stocks To Follow
  302. Biome Grow Expects to Complete First Newfoundland and Labrador-based Cannabis Production Facility in 2018
  303. Biome Grow Announces Name Change of its Nova Scotia-Based ACMPR Licensed Producer to Highland Grow Inc.
  304. Organigram Unveils Comprehensive Suite of Adult Recreational Cannabis Brands
  305. Organigram Announces Receipt of License for Controlled Drugs and Substances from Health Canada
  306. Cannabis Stocks Heat Up on News of $3.2 Billion Aurora & MedReleaf Deal
  307. Aurora Cannabis to Acquire MedReleaf
  308. Opportunity Watchlist: Orca Touchscreen & Cultivator Catalyst Corp. Amalgamation to ‘Biome Grow Inc.’
  309. New on the TSX: InMed Pharmaceuticals
  310. Canadian Cannabis Stocks Continue to Dominate the Market
  311. Organigram Announces First International Expansion Investment
  312. Moody’s Expects Marijuana to See Limited Revenue
  313. Tweed Announces Location of Newfoundland Production Site and First Retail Locations
  314. How to Invest in Cannabis – In Its Many Forms
  315. Should You Invest In Cannabis Stocks?
  316. Top 4 Marijuana Stocks to Watch
  317. CEO Hotline Puts You In The Know
  318. 10 Canadian Marijuana Stocks for Your Portfolio
  319. Pot Stocks To Buy Now
  320. High Hampton Holdings Offers Investors Smart, Diversified Exposure to North America’s Fastest-Growing Marijuana Market
  321. MedMen in Binding ‘Letter of Intent’ To Merge Into Public Company in Canada
  322. American Cannabis Stocks
  323. Orca Touchscreen Enters Into Letter of Intent With Cultivator Catalyst Corp.
  324. Saw that it was covered
  325. Chooses to enjoy a pleasure
  326. These matters to this principle
  327. Heaven and earth seem
  328. Had grass morning
  329. Where they abused her
  330. Replenish itself
  331. I neglect my talents
  332. Grammar resulting language
  333. Where it came from it
Banner Top
  1. Canopy Growth Corporation Reports Third Quarter Fiscal 2019 Financial Results:
  2. Treating Yourself Relaunches Medical Cannabis Website
  3. Sunniva Announces Completion of $15 Million Convertible Debenture Financing
  4. Supreme Cannabis Announces Q2 2019 Financial Results
  5. ‘This is the new Vitamin C’: Biome Grow to sign major CBD source deal
  6. Could Cannabis Cosmeceuticals be the Next Billion Dollar Idea?
  7. Biome Grow announces Memorandum of Understanding to purchase up to 20,000 kg per year of hemp-grown CBD extract from industrial hemp grower CBD Acres
  8. Aurora Releases Q2 Financial Results
  9. O’Cannabiz Toronto Expo, Conference & Industry Awards April 25-27 2019
  10. Biome Grow announces first shipment of finished product to Newfoundland and Labrador
  11. Supreme Cannabis Expands Domestic Distribution to Eight Provinces
  12. 48North Closes its $10 million Private Placement
  13. Aphria’s Board of Directors Rejects Green Growth Brand’s Hostile Takeover Bid
  14. Planet 13 Announces Customer Traffic for January 2019
  15. iAnthus and MPX Bioceutical Announce Closing of $1.6 Billion Business Combination
  16. Namaste Board Launches Strategic Review Process; Announces Termination of CEO Sean Dollinger and Commences Legal Action
  17. World Health Organization Recommends Rescheduling Marijuana Under International Treaties
  18. What Drove Altria’s Revenue in the Fourth Quarter?
  19. Surprise! Tilray’s CEO Just Dumped $11 Million in Stock
  20. Origin House Signs Exclusive Distribution Agreement and Provides Strategic Financing to Utopia Cannabis
  21. Slang, a Canopy Growth-backed Cannabis Company on CSE, off to Half-Billion Dollar Valuation
  22. PharmaCielo Establishes Joint Venture with Mino Labs to Bring Medicinal Cannabis Oil to Mexico
  23. Origin House Signs Exclusive Agreement with Viola Brands for California
  24. TGOD Completes Knud Jepsen Agreement
  25. Green Growth Brands Files Offer to Purchase and Circular for Aphria Inc.; Aphria Urges Shareholders to “Take No Action”
  26. MPX Receives Final Court Approval for Arrangement with iAnthus
  27. Invictus MD Announces Submission Of Its Application To List On NASDAQ And Share Consolidation
  28. HEXO to Begin Trading on the NYSE American, Announces Results of AGM
  29. Nova Scotia’s Highland Grow Secures Second Purchase Order with the NSLC
  30. MPX Securityholders Approve Business Combination with iAnthus
  31. Invictus and GTEC Holdings Announce Formal Termination Of Merger Plans
  32. Biome Opens the Door to U.S. Investors
  33. Aleafia Fulfills First Transaction Under Cannabis Supply Agreement with CannTrust
  34. Aurora to Acquire Whistler
  35. Aphria Releases Q2 Results as Founders Step Down
  36. Curaleaf Set To Expand Operations In Maryland With New Financing And Purchase Option Agreements
  37. PharmaCielo Announces TSX Venture Listing and Provides Corporate Update
  38. Emerald Health Closes Emerald Health Naturals Joint Venture
  39. Biome Grow subsidiary, Highland Grow secures purchase order with NSLC and sends first shipment of finished product
  40. SUPREME CANNABIS RECEIVES CONDITIONAL APPROVAL TO LIST ON THE TORONTO STOCK EXCHANGE
  41. KUSHCO HOLDINGS REPORTS FIRST FISCAL QUARTER 2019 RESULTS
  42. Aurora Cannabis Provides Guidance for the Second Quarter of Fiscal 2019, Anticipating Net Revenues of $50M to $55M
  43. Curaleaf Launches Its 20th Medical Marijuana Dispensary in Florida
  44. iAnthus Opens Flagship Citiva Dispensary in Brooklyn
  45. TGOD Signs a Commercial Sublicense with EnWave and Tilray to Dry Cannabis in Canada
  46. The Fastest-Growing Marijuana Stocks in 2019
  47. Biome Announces OTCQB Listing
  48. Green Growth Brands Launches Hostile Takeover Bid for Aphria Inc.
  49. Cannabis Stocks Mixed on Monday
  50. Health Canada Announces Proposed Regulations for Cannabis Edibles, Extracts, and Topicals
  51. Northland Capital Initiates Coverage on Planet 13 Holdings
  52. Details on Ontario’s New Private Cannabis Retail Lottery
  53. GrowHealthy Opens First Flagship Dispensary in Florida, With Plans for Two More by End of 2018
  54. Biome Grow Receives Amended Health Canada Sales License for its Nova Scotia-based Highland Grow.
  55. Canada’s Largest Province To Approve Only 25 Store Licences Due to Supply Shortage
  56. The Next Cannabis Wave? A $3.7 Trillion Wellness Market
  57. Canopy Growth announces multi-year extraction agreement with Valens GroWorks
  58. Here’s Why Marijuana Stocks Deserve Coal in Their Stockings This Year
  59. Biome Receives DTC Eligibility in United States, OTC symbol “ORTFF”
  60. U.S. House of Representatives Passes the Farm Bill
  61. Mississauga and Markham Opt-Out of Cannabis Retail Stores
  62. Interview with Diane Scott, Chairman and Chief Executive Officer, Jamaican Medical Cannabis Corporation (JMCC)
  63. Canada’s Aurora Cannabis buys Mexico’s Farmacias Magistrales
  64. Altria Moves into the Herd
  65. Cronos group inc. Announces c$2.4 billion strategic investment from altria group, inc
  66. Canopy Acquires Storz & Bickel
  67. CANNABIS MEETS HEALTHCARE
  68. Aphria Shares Down this Morning
  69. 48North Has Two Major Announcements
  70. Cannabis stock report: Congress agrees on new farm bill legislation, CBD industry readies to explode
  71. Cannabis Daily’s Top 35 Stocks Now Updated
  72. iAnthus Announces Third Quarter 2018 Financial Results
  73. Green Thumb Industries (GTI) Announces Year-over-Year Revenue Growth of 344% and Sequential Revenue Growth of 26% for Third Quarter 2018
  74. 48North Cannabis Corp. Announces Revenue Growth for Fiscal Q1 2019
  75. KUSHCO HOLDINGS REPORTS FISCAL YEAR 2018 RESULTS
  76. Canada’s Grand Cannabis Experiment Has Set Scientists Free
  77. What Did Canadian Cannabis Legalization Do to the Stock Markets?
  78. Cannabis 3.0?
  79. Cannabis firms spent millions marketing their pot last quarter – did it work?
  80. Biome Grow, Now Publicly Traded but Falling Under the Radar
  81. John Boehner-Backed Pot Firm Sees This Boosting U.S. Weed Listings
  82. MJBizCon Las Vegas Redefines Scale in Cannabis Trade Shows
  83. Ontario Establishes Strict Regulations for the Licensing and Operation of Private Cannabis Stores
  84. Canopy Growth Losses Widen Sharply, But Cannabis Sales Prices Spike
  85. Biome Grow subsidiary, Highland Grow, receives license to sell to other licensed producers from Health Canada
  86. Université de Moncton partners with the Government of Canada, Genome Atlantic, Genome Canada, New Brunswick Innovation Foundation, and Organigram to advance cannabis research and increase productivity
  87. Aurora Cannabis Earnings Kick Off Big Week For Marijuana Stocks After Canada Recreational Legalization
  88. Legalization… What’s Next?  Clear the Smoke at O’Cannabiz Conference and Expo Vancouver
  89. Biome Grow announces supply and production agreement with Province of Newfoundland and Labrador, including distribution and retail services
  90. Trump ousts Jeff Sessions as attorney general
  91. Marijuana Stocks Moved Higher On Election Results
  92. Is the cannabis industry armed against privacy breaches?
  93. Is Emblem Corp (CVE:EMC) A Financially Sound Company?
  94. Midterm elections and marijuana: Part III, recreational use initiatives
  95. Biome Grow’s Announcement in Newfoundland Demonstrates its Large-Scale Commitment to Atlantic Canada
  96. Cannabis Stocks Reversed Some Losses Last Week
  97. O’Cannabiz Vancouver Brings Together Montel Williams, Leading Cannabis Advocates and Innovators
  98. Forget October: Here’s the Right Marijuana Move for Investors Now
  99. Better Marijuana Stock: Canopy Growth vs. Canopy Rivers
  100. Biome Grow (BIO.C) signs huge supply deal with Newfoundland
  101. Aurora Cannabis Receives Lenders’ Consent for Proposed Acquisition of ICC
  102. Spectrum Cannabis welcomes JWC dried cannabis products to its online platform
  103. 3 Marijuana Stocks Taking Advantage of Global CBD Growth
  104. Falling Pot Stocks Hammer Canada’s Struggling Venture Exchange
  105. Cannabis Sector Didn’t Fare So Well Last Week
  106. How Pot Chain MedMen Sounds Like A Typical Retailer With This New Plan
  107. Biome Grow Introduces Ontario-based brand, Great Lakes Cannabis
  108. Kushco Holdings Joins Sustainable Packaging Coalition
  109. Sales of Marijuana in Colorado Continue to Climb
  110. Monday Morning Coming Down
  111. Biome Grow Introduces PEI Brand, Red Sands Craft Cannabis Co.
  112. Mary’s Wellness Pitching CBC Dragon’s Den Tonight
  113. Biome Grow Announces Listing on the Frankfurt Stock Exchange under symbol 60TA
  114. Home-Use THC and CBD Test Kits Now Available in Canada
  115. Looking for Work in Cannabis? Careers Cannabis’ New Platform Launches Today
  116. Canada becomes first industrialised nation to legalise cannabis
  117. Biome Grow is Investing in Atlantic Canadian Cannabis Sector
  118. The Canadian Province With The Most Pot Smokers Was Just Revealed And It’s Not At All Who You Thought It Would Be
  119. The Cannabis Society and Fireside Cannabis presents Canada’s Legalization party.
  120. Cannabis companies ramp up marketing as Health Canada warns them not to advertise pot
  121. CBP Statement on Canada’s Legalization of Marijuana and Crossing the Border
  122. Flower One Commences Trading on the CSE
  123. Canopy Growth Completes First Legal Medical Cannabis Export from Canada to the United States
  124. Aurora Cannabis Announces Application to List on the NYSE
  125. BIOME GROW Begins Trading on CSE Under Symbol (BIO)
  126. Remember When?
  127. NICHE Canada’s Cannabis & Our Community Series Continues in Calgary October 23rd
  128. Biome Grow Closes Fundamental Change Transaction
  129. 10 Of The Richest Cannabis Millionaires — And How They Made Their Money
  130. Cannabis Sector Down After Pepsi’s Statement
  131. Rumors of a Crop Failure at Canopy’s Aldergrove, BC Facility
  132. Dixie Brands, Inc. Going Public, Expanding Operations
  133. As Major Beverage Companies Eye Cannabis Industry, Consumer Trends Expected to Follow Suit
  134. Cannabis company withdraws ‘Chronic by Dre’ trademark it filed without Dr. Dre’s permission
  135. Aphria unveils comprehensive portfolio of adult-use brands
  136. DEA Greenlights Epidiolex. What’s Next for CBD and the Cannabis Industry?
  137. SUPREME CANNABIS SIGNS CANNABIS SUPPLY AGREEMENT WITH TILRAY®
  138. New Ontario Cannabis Regulations Could Be a Breath of Fresh Air
  139. Our first exposure to The Cannabis Society both eye-opening and insightful
  140. Cannabis Sector Stayed in the Green Last Week
  141. Aurora Cannabis releases earnings, confirms U.S. listing plans
  142. Who is Biome Grow and What a Good Business Plan Means to Cannabis Investors
  143. Keep your arms and legs in the car at all times…
  144. Aphria Signs Supply Agreements with all Provinces and Yukon
  145. The Stock That Can’t Stay Out of the News
  146. Tilray Led Cannabis Stocks Higher as Sector Continues to Rally
  147. Tilray Drops Namaste Contract
  148. Coca-Cola and Aurora. Is it the Real Thing?
  149. CEO Hotline – Greg Pantelic, Think AHLOT Corporation
  150. Global Cannabis Partnership Welcomes New Members
  151. iAnthus Capital Holdings, Inc. Announces $30 Million Bought Deal Financing
  152. Organigram signs supply agreement with Newfoundland and Labrador Liquor Corporation
  153. Aphria Announces Director Resignation and Appointment
  154. Emblem launches Atmosphere, Its First Oral Dose-Metered Spray
  155. Organigram invests in Hyasynth Biologicals Inc.
  156. Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
  157. Insights on the Cannabis Industry
  158. Rolling Stone: New Report Predicts CBD Market Will Hit $22 Billion by 2022
  159. NICHE Canada and Aurora Cannabis Launch Guide for Municipal Candidates on Cannabis Legalization and Implementation
  160. Aurora Cannabis-ICC Labs Deal Fuels Marijuana Stock Momentum
  161. EVENT: Cannabis & Our Community – Toronto, Sept 25, 2018
  162. Invictus CEO Update: Building a vertically integrated, horizontally diverse cannabis company
  163. Cannabis Daily and Puffin Style Media Sponsorships
  164. Marijuana Stocks: Short-Seller Citron Research Puts Tilray Stock In Cross Hairs
  165. Demystifying the Science and Economics of Smart Temperature and Humidity Control
  166. Vertical Integration
  167. Take a Deep Dive into Highland Grow’s Antigonish, Nova Scotia Operation
  168. Emerald Health Therapeutics Reports 2nd Quarter 2018 Financial Results and Provides Corporate Update
  169. iAnthus Announces Second Quarter 2018 Financial Results
  170. Starseed Holdings Inc. Launches Saturday, its New Adult-Use Cannabis Brand
  171. Supreme Cannabis Secures Supply Agreements with Nova Scotia and Prince Edward Island
  172. Nova Scotia cannabis distributor hopes local products will be on NSLC shelves by Oct. 17
  173. Cannabis ETF Surges as Alcohol Industry Looks to Marijuana
  174. Aphria selected by the Nova Scotia Liquor Corporation to supply Nova Scotia’s adult-use cannabis market
  175. AB InBev, Pepsi, Coca-Cola All Likely Eyeing Cannabis: Former Alcohol Industry Exec
  176. Biome Grow announces conditional approval for listing on the Canadian Securities Exchange
  177. The Best Under-the-Radar Marijuana Stock I’ve Seen So Far
  178. Biome Grow – Investor Awareness Event
  179. Pot stocks rampage amid expectations of more big deals with traditional companies
  180. Cannabis Daily Launches Cannabis Lifestyle Website
  181. Organigram signs supply agreement with Nova Scotia Liquor Corporation
  182. Cannabis Drinks Expo Announces Canopy Growth Corp. CEO Bruce Linton Will Headline Event
  183. Aurora Cannabis Obtains Health Canada Approval for Softgel Capsule Production: Launches CanniMed Capsules 3:3
  184. The MJBizCon Int’l Conference Brought American Canna-Business to Toronto
  185. Aphria Signs Agreement with OCS
  186. The OCS Announces its Suppliers
  187. Emerald Health Therapeutics Announces Appointment of Pure Sunfarms President and CEO
  188. Weed’s Big Day
  189. The Green Organic Dutchman Signs Agreement to Acquire Leading European CBD Company HemPoland
  190. Let's Face It: Marijuana Stocks Won't Live Up to the Hype
  191. Aurora Cannabis and MedReleaf Confirm Supply Agreements with Ontario Cannabis Stores
  192. Organigram becomes an official cannabis supplier to the Province of Ontario, Canada’s largest adult recreational market
  193. Canopy Growth secures over 100 product listings in Ontario
  194. The Google of Cannabis? Hmm…
  195. Dry Counties
  196. TGOD Reports $8.5M Loss for Quarter ended June 30, 2018
  197. Kush Bottles Launches Their Canadian Division
  198. Cannabis company Canopy Growth’s stock soars 30% as Corona brewer increases stake
  199. Aurora Cannabis and McGill University Partner in International Research Project
  200. Constellation Brands makes additional $4 billion investment in cannabis company Canopy Growth
  201. Are Cannabis Investors Forgetting the Lessons of the Dot Com Era? First-to-Market May Not Win.
  202. THC BioMed Develops Cannabis Beverage
  203. What’s the Analyst Consensus on Aphria?
  204. Canopy Growth Completes Canopy Health Innovations Acquisition
  205. Has Canadian Marijuana Officially Bypassed Mainstream and Gone Corporate?
  206. How Trump’s trade battles are affecting the marijuana industry
  207. Aphria Records Higher Annual Sales and Higher Quarterly Loss Due to Pending Canadian Legalization
  208. 48North Invites Women To Speak-Up About Their Cannabis Use
  209. ABcann to Acquire Leading B.C. Producer Canna Farms
  210. Ontario said to announce big change in plans for marijuana retailing under Doug Ford
  211. The Greenfield 4:20 Fire and its Implications
  212. Aurora Cannabis and MedReleaf Close the World’s Largest Cannabis Industry Transaction
  213. CEO Hotline: Khurram Malik, Interim CEO, Biome Grow
  214. Marijuana operator Acreage Holdings announces landmark $119 million funding
  215. Cannabis Sector Continued to Slide Last Week
  216. Aphria provides update on investments
  217. Aurora, MedReleaf shareholders clear path toward Canada’s largest cannabis deal
  218. Step into the first virtual reality cannabis dispensary
  219. One Stop Shops? Not with the Kids. NSLC Shows Their Store.
  220. Khiron Appoints Former Mexican President Vicente Fox to Board of Directors
  221. Selling Cannabis in Jamaica – Wait…What?
  222. Aurora Cannabis Selects Shopify to Power Global ECommerce Platform
  223. British Columbia’s Liquor Board Announces the Province’s 31 Bud Suppliers
  224. Kush Bottles Reports Third Fiscal Quarter 2018 Results, Name Change and Restructuring
  225. Canopy Growth Moves to Acquire Hiku Brands Company
  226. Biome Grow Announces Appointment of Steven Poirier to its Board of Directors
  227. Alberta Announces the ‘Lucky 13’
  228. Canada to legalise smoking pot: Can these stocks smoke the ASX?
  229. Legal Marijuana Is Coming to Canada. Investors Catch the Buzz.
  230. Analyst Recommendations for Two Leading Cannabis Stocks
  231. Cannabis Promotion in Canada? See Tobacco. Tobacco Promotion in Canada? See Kryptonite.
  232. CEO of the Green Organic Dutchmen Resigns, New CEO and CFO Appointed
  233. 3 Best Marijuana Stocks of 2018 So Far — Are They Buys Now?
  234. CEO Hotline: The Cannabis Executive Search Agency
  235. Canadian Company Makes Historic Investment in Jamaican Medical Cannabis Research
  236. Orca Touchscreen Technologies Shareholders Approve Amalgamation with Biome Grow
  237. Why Canopy Growth Corp’s Shares Plunged 12% Today
  238. TGOD Holdings Accelerates European Expansion with Denmark Joint Venture
  239. Cann Group secures Australia’s largest medicinal cannabis operation
  240. Top Four Developments We’re Watching in Cannabis Sector: Part 2
  241. Aurora Cannabis signs loan deal for up to $250 million with Bank of Montreal
  242. Cannabis Drinks Gaining Visibility
  243. B.C. Announces Central Cannabis Warehouse and Online Platform
  244. Six Key Differentiation Points for the Cannabis Market in Canada
  245. Canada Legalizes Recreational Marijuana: What’s Next for Pot Stocks?
  246. Cultivator Catalyst Corp to go public with tech firm Orca
  247. Move Over Tech: Marijuana Stocks Are the New Star
  248. The Post-Prohibition Era in Canada Begins
  249. Canadian Senate Approves Bill C-45
  250. High Times refreshes IPO plans as cannabis companies build buzz on Wall Street
  251. Weed VR – Future Tech Today
  252. 48North Launches Scholarship Program for Entrepreneurial Women in Cannabis
  253. CannTrust strives to be a leader in the cannabis industry with a 450,000 square foot facility in Niagara, ON.
  254. Biome Grow announces agreement to acquire Weed Virtual Retail
  255. Here’s how Canada compares with the rest of the world when it comes to cannabis legalization
  256. CannabisMD and CBD’s Medicinal Application
  257. Khiron Life Sciences First To Enter 5-Million Strong Colombia Medical Cannabis Market
  258. House of Commons to Reinstate Rights of Canadians to Grow Cannabis
  259. Welcome to Cannada -Part 3. The New Cannabis Economy
  260. Cannabis Delivery Services: Curation and Connection
  261. Avoid These Obvious Mistakes When Investing In Cannabis Stocks
  262. 5 Must-See Quotes From Aurora Cannabis on Worldwide Weed Opportunities
  263. Trump Signals Support for Legislation Easing US Ban on Pot
  264. Large Indoor Hydroponic Facility – New On the CSE
  265. A Hitchhiker’s Guide to Recreational Cannabis
  266. CEO of Lift & Co’s Consumer-Centric Vision
  267. On the Morning of Canadian Senate Vote, Weed Stocks Down
  268. 2nd Annual O’Cannabiz Conference Toronto
  269. Now Growing More Than Tomatoes & Cucumbers
  270. Welcome to Cannada -Part 2. The Cannabis Stock Exchange
  271. Newfoundland and Labrador’s Back Home Medical Cannabis Corp. becoming a reality thanks to investment from Biome Grow
  272. Welcome to Cannada. Part I – The Canadian Cannabis Future
  273. Deloitte Reports that Canadians Will Spend $7.2B Next Year on Cannabis
  274. As C-45 Passage Approaches, Greg Engel, CEO of OrganiGram, Shares His Thoughts
  275. Organigram Enters into Non-Binding Term Sheet for 26% Equity Interest in Eviana Health Corporation
  276. On the Verge of Becoming Canada’s Largest Cannabis Producer
  277. Khiron Life Sciences Corp. New on the TSX – Medical Cannabis for Latin America
  278. C-45 Progresses in the Canadian Senate as the Industry Ramps Up
  279. 8 Canadian Marijuana Growers Expected to Top 100,000 Kilograms of Annual Production
  280. Canopy Growth Announces Five Retail Locations in Saskatchewan
  281. MedMen CEO Sees Untapped Potential in Marijuana Market
  282. Canopy Growth Corporation announces entry into the African market with acquisition of Daddy Cann Lesotho
  283. Meet Nova Scotia’s 3 legal cannabis growers
  284. JMCC Aims to Supply Canadian LPs with Jamaican Premium Cannabis
  285. MedMen Begins Trading Under Ticker Symbol “MMEN” on the Canadian Securities Exchange
  286. MedReleaf and BioPharma Services Inc. Announce Strategic Alliance
  287. Cannabis Sector Back in the Red for Week Ended May 25
  288. What Investors Are Paying for Cannabis Sector’s Forward Sales
  289. As Ontario Votes, We Ask the Candidates Where They Stand on Cannabis.
  290. Biome announces acquisition of land in Nova Scotia to dramatically increase the production footprint of its ACMPR Licensed Producer
  291. With Legalization Colorado Invited Growers into the State. Here’s What Happened
  292. Looking for Work Women? Perhaps the Grass is Greener in the Cannabis Industry
  293. Organigram Announces Letter of Intent for Strategic Investment in Hyasynth Biologicals Inc.
  294. Highland Grow Inc. Boosts its Quality Assurance and Regulatory Compliance Ranks
  295. Lift & Co. Cannabis Expo Illustrates the Changing Nature of the Business
  296. Diagnostics, Testing and Support – The Coming Wave
  297. From the Big Smoke to the Big Board
  298. Biome Grow expects completion of first province-based cannabis production facility this year
  299. Oils – Are They Secret Sauce to Profitability?
  300. Organigram Receives Permit to Export Medical Cannabis to Australia
  301. Morning Briefing -Top 9 Stocks To Follow
  302. Biome Grow Expects to Complete First Newfoundland and Labrador-based Cannabis Production Facility in 2018
  303. Biome Grow Announces Name Change of its Nova Scotia-Based ACMPR Licensed Producer to Highland Grow Inc.
  304. Organigram Unveils Comprehensive Suite of Adult Recreational Cannabis Brands
  305. Organigram Announces Receipt of License for Controlled Drugs and Substances from Health Canada
  306. Cannabis Stocks Heat Up on News of $3.2 Billion Aurora & MedReleaf Deal
  307. Aurora Cannabis to Acquire MedReleaf
  308. Opportunity Watchlist: Orca Touchscreen & Cultivator Catalyst Corp. Amalgamation to ‘Biome Grow Inc.’
  309. New on the TSX: InMed Pharmaceuticals
  310. Canadian Cannabis Stocks Continue to Dominate the Market
  311. Organigram Announces First International Expansion Investment
  312. Moody’s Expects Marijuana to See Limited Revenue
  313. Tweed Announces Location of Newfoundland Production Site and First Retail Locations
  314. How to Invest in Cannabis – In Its Many Forms
  315. Should You Invest In Cannabis Stocks?
  316. Top 4 Marijuana Stocks to Watch
  317. CEO Hotline Puts You In The Know
  318. 10 Canadian Marijuana Stocks for Your Portfolio
  319. Pot Stocks To Buy Now
  320. High Hampton Holdings Offers Investors Smart, Diversified Exposure to North America’s Fastest-Growing Marijuana Market
  321. MedMen in Binding ‘Letter of Intent’ To Merge Into Public Company in Canada
  322. American Cannabis Stocks
  323. Orca Touchscreen Enters Into Letter of Intent With Cultivator Catalyst Corp.
  324. Saw that it was covered
  325. Chooses to enjoy a pleasure
  326. These matters to this principle
  327. Heaven and earth seem
  328. Had grass morning
  329. Where they abused her
  330. Replenish itself
  331. I neglect my talents
  332. Grammar resulting language
  333. Where it came from it
Provides Cronos Group with Additional Capital and Complementary Expertise to Accelerate Its Expansion and Innovation in the Rapidly Growing Global Cannabis Industry

TORONTO, December 7, 2018 – Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that it has entered into a subscription agreement (the “Subscription Agreement”) with Altria Group, Inc. (NYSE: MO) (“Altria”) pursuant to which Altria has agreed to make an approximately C$2.4 billion equity investment in Cronos Group (the “Transaction”) on a private placement basis in exchange for common shares in the capital of the Company (the “Shares”). Altria will also receive Warrants of Cronos Group (the “Warrants”), that if fully exercised, would provide the Company with an additional approximately C$1.4 billion of proceeds. The Shares issuable to Altria pursuant to the Subscription Agreement will result in Altria holding an approximately 45% ownership interest in Cronos Group (calculated on a non-diluted basis), exercise of the Warrants would result in incremental ownership of 10% for a total potential ownership position of 55%. This strategic partnership provides Cronos Group with additional financial resources, product development and commercialization capabilities, and deep regulatory expertise to better position the Company to compete, scale and lead the rapidly growing global cannabis industry.

“Altria is the ideal partner for Cronos Group, providing the resources and expertise we need to meaningfully accelerate our strategic growth,” said Cronos Group’s Mike Gorenstein, Chairman, President and Chief Executive Officer. “The proceeds from Altria’s investment will enable us to more quickly expand our global infrastructure and distribution footprint, while also increasing investments in R&D and brands that resonate with our consumers. Importantly, Altria shares our vision of driving long-term value through innovation, and we look forward to continuing to differentiate in this area. As one of the largest holding companies in the adult consumer products sector, Altria has decades of experience in regulatory, government affairs, compliance, product development and brand management that we expect to leverage, particularly as new markets for cannabis open around the world.”

“Investing in Cronos Group as our exclusive partner in the emerging global cannabis category represents an exciting new growth opportunity for Altria,” said Howard Willard, Altria’s Chairman and Chief Executive Officer. “We believe that Cronos Group’s excellent management team has built capabilities necessary to compete globally, and we look forward to helping Cronos Group realize its significant growth potential.”

 

Benefits of the Transaction

  • Accelerates Cronos Group’s pace of growth and expansion. The growth opportunities for Cronos Group are significant and extend across the globe as markets open. With Altria’s resources, Cronos Group expects to be even better positioned to support cannabinoid innovation, create differentiated products and brands across medicinal and recreational categories, and expand its global footprint and growing production capacity.
  • Bolsters Cronos Group’s ability to be an innovation leader in the cannabis industry. Cronos Group’s research collaborations with Gingko Bioworks to develop cultured cannabinoids and its partnership with the Technion Research and Development Foundation for cannabinoid-based skin care treatments are just two recent examples of how the Cronos Group intends to use innovation and its growing intellectual property portfolio to develop new applications for cannabinoids across a range of products and categories. Altria shares Cronos Group’s commitment to innovation, medical cannabis research and state of the art product development.
  • Leverages Altria’s product design, manufacturing, marketing and distribution capabilities and expertise. Cronos Group expects to work with Altria to rapidly expand its product offerings in markets as regulations permit, including device technology. Altria has significant expertise that can serve as building blocks for cannabis vape products. Altria also brings considerable experience with large-scale manufacturing automation, pre-roll technology and supply chain management. In addition, by investing the incremental capital, Cronos Group expects to enhance its attractiveness as a potential partner to other medicinal and consumer focused partners that may work with the Company to further expand its product offerings and distribution capabilities for the benefit of its shareholders.
  • Provides expertise in successfully navigating complex regulatory landscapes. Altria has a strong record of managing multi-faceted regulatory, compliance and government affairs environments related to taxation, product registration, shipping and other legal issues that Cronos Group expects to be able to leverage as cannabis markets develop and open around the world.
  • Raises capital at a premium valuation and delivers even greater upside opportunities for Cronos Group shareholders, employees and partners. Under the terms of the agreement, Altria has agreed to acquire 146.2 million Shares at a price of C$16.25 per Share. The price per Share represents a 41.5% premium to the Company’s 10-day volume weighted average price (“VWAP”) on the TSX, ending November 30, 2018, the last unaffected trading day prior to when Cronos Group publicly disclosed preliminary discussions with Altria. The strategic investment combined with Altria’s expertise and complementary capabilities are expected to better position Cronos Group for significant growth and value creation with benefits to all of the Company’s stakeholders, including its holders of Shares (the “Shareholders”), employees and partners.

 

Board Recommendation

The Board of Directors of Cronos Group (the “Board”), after consultation with its legal and financial advisors, has unanimously determined that the Transaction is in the best interest of Cronos Group and is unanimously recommending that Shareholders vote in favor of the Transaction. The Board has received an opinion from its financial advisor, Lazard Canada Inc., that as of the date thereof and subject to the assumptions, qualifications and limitations set forth therein, the consideration to be received by the Company pursuant to the Transaction is fair, from a financial point of view, to the Company.

 

Key Transaction Terms

Equity Investment

Pursuant to the Subscription Agreement, Altria has agreed to acquire 146.2 million Shares at closing at a price of C$16.25 per Share, which represents a 41.5% premium to the 10-day VWAP of the Shares on the TSX on November 30, 2018, the last unaffected trading day prior to when Cronos Group publicly disclosed preliminary discussions with Altria.

Altria will also receive Warrants at closing entitling it to acquire up to an additional 10% ownership position in the Company exercisable from time to time, for a period of four years following closing for an exercise price of C$19.00 per Share, which represents an implied premium of 65.5% to the 10-day VWAP of the Shares on the TSX on November 30, 2018. Altria’s ownership interest in Cronos Group would be approximately 55% (calculated on a non-diluted basis). Additionally, the Warrants will contain certain anti-dilution provisions.

 

Governance Rights

Pursuant to an investor rights agreement to be entered into, at closing (the “Investor Rights Agreement”), Altria will have the right to nominate four directors, including one independent director, to serve on the Board of Directors of Cronos Group, which will be expanded from five to seven directors in connection with the Transaction.

 

Altria’s Exclusive Cannabis Partner

Under the Investor Rights Agreement, Altria has agreed to make Cronos Group its exclusive partner for pursuing cannabis opportunities throughout the world (subject to certain limited exceptions.

At closing, the parties are also expected to enter into commercial support agreements under which Altria will provide services relating to marketing and brand management, government affairs, regulatory affairs, and research and development.

 

Closing and Approvals

The Transaction is expected to close in the first half of 2019, subject to certain customary closing conditions including the receipt of approval from the TSX, and receipt of regulatory approval pursuant to the Investment Canada Act. In addition, under applicable TSX rules, the Transaction will require approval by at least the majority of the votes cast by Shareholders present at a special meeting of Shareholders as the Transaction is expected to materially affect control of Cronos Group.

 

Additional Information

Further information regarding the transaction will be included in the management information circular to be mailed to Shareholders in connection with the Company’s special meeting of Shareholders to approve the transaction. Copies of the Subscription Agreement and the agreements attached thereto as exhibits, including the form of Warrant and the form of Investor Rights Agreement, will be filed on the Company’s profile on SEDAR at www.sedar.com and EDGAR at www.sec.gov. The above descriptions of the terms and conditions of the Subscription Agreement and the agreements attached thereto as exhibits, including the form of Warrant and the form of Investor Rights Agreement, are qualified in their entirety by the terms of the Subscription Agreement which will be filed on the Company’s profile on SEDAR at www.sedar.com and EDGAR at www.sec.gov.

 

Advisors

Lazard Canada Inc. is serving as financial advisor to Cronos Group, and Sullivan & Cromwell LLP and Blake, Cassels & Graydon LLP are legal counsel.

Perella Weinberg Partners LP is serving as financial advisor to Altria, and Wachtell, Lipton, Rosen & Katz and Goodmans LLP are legal counsel. Hunton Andrews Kurth LLP is providing legal counsel to Altria regarding the financing.

 

Analyst / Investor Conference Call and Webcast

Cronos Group will host a conference call and webcast today, Friday, December 7 at 8:30 a.m. ET to discuss today’s announcement.

The conference call can be accessed by dialing (647) 427-7450 for callers from the U.S. and (888) 231-8191 for international callers. The confirmation code is 9359909.

A live webcast of the conference call will be available at https://thecronosgroup.com/investor-relations.

A replay of the conference call will be available for approximately two weeks, from December 7, 2018 through December 21, 2018, and can be accessed by dialing (855) 859-2056 and providing the 9359909 confirmation code.

The webcast will also be archived at https://thecronosgroup.com/investor-relations.

 

About Cronos Group

Cronos Group is a globally diversified and vertically integrated cannabis company with a presence across five continents. Cronos Group operates two wholly-owned Canadian licensed producers: Peace Naturals Project Inc., which was the first non-incumbent medical cannabis license granted by Health Canada, and Original BC Ltd., which is based in the Okanagan Valley, British Columbia. Cronos Group has multiple international production and distribution platforms across five continents. Cronos Group intends to continue to rapidly expand its global footprint as it focuses on building an international iconic brand portfolio and developing disruptive intellectual property. Cronos Group is committed to building industry leading companies that transform the perception of cannabis and responsibly elevate the consumer experience.

 

About Altria

Altria’s wholly-owned subsidiaries include Philip Morris USA Inc., U.S. Smokeless Tobacco Company LLC, John Middleton Co., Sherman Group Holdings, LLC and its subsidiaries, Nu Mark LLC, Ste. Michelle Wine Estates Ltd. (Ste. Michelle) and Philip Morris Capital Corporation. Altria holds an equity investment in Anheuser-Busch InBev SA/NV (AB InBev).

The brand portfolios of Altria’s tobacco operating companies include Marlboro®, Black & Mild®, Copenhagen®, Skoal®, VERVE®, MarkTen® and Green Smoke®. Ste. Michelle produces and markets premium wines sold under various labels, including Chateau Ste. Michelle®, Columbia Crest®, 14 Hands® and Stag’s Leap Wine Cellars™, and it imports and markets Antinori®, Champagne Nicolas Feuillatte™, Torres® and Villa Maria Estate™ products in the United States. Trademarks and service marks related to Altria referenced in this release are the property of Altria or its subsidiaries or are used with permission. More information about Altria is available at altria.com and on the Altria Investor app.

Take a closer look at Altria and its companies on altria.com.

Follow Altria on Twitter at @AltriaNews.

 

Forward-Looking Statements

This communication contains “forward-looking information” and “forward-looking statements” within the meaning of applicable securities laws (collectively, “forward-looking statements”). All statements contained herein that are not clearly historical in nature may constitute forward-looking statements. In some cases, forward-looking statements can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Forward-looking statements include estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of historical fact. Forward-looking statements are provided for the purposes of assisting the reader in understanding our financial performance, financial position and cash flows as at and for periods ended on certain dates and to present information about management’s current expectations and plans relating to the future and the reader is cautioned that such information may not be appropriate for any other purpose. Some of the forward-looking statements contained in this communication, include, but are not limited to, statements with respect to: the proposed investment by Altria Group in Cronos Group (the “proposed transaction”), our business and operations, our strategy for future growth, expanding our global footprint, including the timing thereof, our intention to build an international iconic brand portfolio and develop disruptive intellectual property and our ability to build an industry leading company that transforms the perception of cannabis and responsibly elevates the consumer experience. No forward-looking statement can be guaranteed and Cronos Group cannot guarantee the future statements contained herein. Forward-looking statements are based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including management’s perceptions of historical trends, current conditions and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances. While we consider these assumptions to be reasonable based on information then currently available to management, there is no assurance that such expectations will prove to be correct. By their nature, forward-looking statements are subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking statements in this communication. Such factors include, without limitation, the ability to complete the proposed transaction between Cronos Group and Altria Group on anticipated terms and timetable; the ability to obtain approval by the shareholders of Cronos Group related to the proposed transaction and the ability to satisfy various other conditions to the closing of the transaction contemplated by the subscription agreement; the ability to obtain governmental approvals of the proposed transaction on the proposed terms and schedule, any conditions imposed on the parties in connection with consummation of the proposed transaction; the risk that the cost savings and any other synergies from the proposed transaction may not be fully realized or may take longer to realize than expected; disruption from the proposed transaction making it more difficult to maintain relationships with customers, employees or suppliers; future levels of revenues; consumer demand for cannabis products; Cronos Group’s ability to manage disruptions in credit markets or changes to its credit rating; future levels of capital, environmental or maintenance expenditures, general and administrative and other expenses; the success or timing of completion of ongoing or anticipated capital or maintenance projects; the business strategies, growth opportunities and expected investment; the adequacy of our capital resources and liquidity, including but not limited to, availability of sufficient cash flow to execute our business plan (either within the expected timeframe or at all); the potential effects of judicial or other proceedings on our business, financial condition, results of operations and cash flows; continued or further volatility in and/or degradation of general economic, market, industry or business conditions; compliance with applicable environmental, economic, health and safety, energy and other policies and regulations; the anticipated effects of actions of third parties such as competitors, activist investors or federal (including U.S. federal), state, provincial, territorial or local regulatory authorities, self-regulatory organizations or plaintiffs in litigation; and the factors discussed in Cronos Group’s current MD&A and Annual Information Form, both of which have been filed on SEDAR and EDGAR and can be accessed at www.sedar.com and www.sec.gov, respectively. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements. Forward-looking statements contained herein are made as of the date of this communication and are based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking statements are made. Cronos Group undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking statements, except as required by applicable law or regulation.

For further information, please contact:
The Cronos Group
Anna Shlimak
Investor Relations
Tel: (416) 504-0004
investor.relations@thecronosgroup.com

Media Contact
Adam Pollack or Mahmoud Siddig
Joele Frank, Wilkinson Brimmer Katcher
(212) 355-4449

Please Note: Where available, an audio recording of the conference call and / or an archived webcast will be made available on Cronos Group’s website for a minimum of 30 days following the conference call or webcast.  While information contained within these releases was believed to be accurate at the time of issue, the Company will not, and specifically disclaims any duty to, update this information.

Tags: , , ,

Important Links

Sponsored Message

View Rate Card